Azaindoles for inhibiting aurora2 and other kinases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 17, 2011
Grant Date -
Dec 1, 2005
app pub date -
Nov 23, 2004
filing date -
Jun 21, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention is directed to physiologically active compounds of general formula (I):—and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully